| HOME >> MEDICINE >> TECHNOLOGY |
• Focus resources to maximize the effectiveness of your budget
• Understand where your product fits
• Understand where your competitor's product fits
• Design messages to advance brand performance
Table of Contents
Executive Summary5
Chapter 1: Introduction7
Table 1: Treatment Options in Advanced Lung Cancer7
Chapter 2: Respondent Demographics9
Table 2: Eligibility Criteria for Survey Participation9
Figure 2.1 Gender of Survey Respondents9
Figure 2.2 Years since Medical School Graduation10
Figure 2.3 Practice Settings10
Figure 2.4 Practices in NCI Cancer Centers11
Figure 2.5 Geographic Settings11
Figure 2.6 Survey Respondents by State's Lung Cancer Mortality12
Figure 2.7 Number of Physicians in Practice Groups13
Figure 2.8 Minimal Acceptable Level of Evidence in Determining Treatment Regimen13
Chapter 3: Treatment of a Smoker with Squamous Cell Carcinoma14
Figure 3.1 Laboratory studies to be done on the tumor tissue14
Figure 3.2 First line chemotherapy regimen15
Figure 3.3 Factors Influencing Treatment Decisions16
Figure 3.4 Confidence in treating this patient to an optimal outcome18
Figure 3.5 Next step in management19
Figure 3.6 Subsequent treatment regimen21
Figure 3.7 Treatment at next cancer progression22
Figure 3.8 Factors influencing treatment decisions23
Figure 3.9 Barriers to management of advanced lung cancer25
Chapter 4: Summary27
Appendix A: Survey Instrument29
Companies mentioned
Eli Lilly, Genentech/Roche, Bristol-Myers Squibb, Glaxo Smith Kline, Pfizer, Sanofi-aventis
To order this report:
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |